Literature DB >> 1655958

Gangliosides as binding sites in SA-11 rotavirus infection of LLC-MK2 cells.

F Superti1, G Donelli.   

Abstract

The chemical nature of receptors involved in the attachment of simian rotavirus (SA-11) to a monkey kidney cell line (LLC-MK2) was investigated. Enzymic treatment of cells before virus infection indicated that membrane proteins and phospholipids are not involved in virus attachment, whereas sialic acid and galactose participate in the receptor structure to differing extents. Incubation of SA-11 with bovine brain gangliosides before infection strongly reduced its ability to bind to cell membranes. Similar experiments with individual purified gangliosides from bovine brain showed that virus infection was prevented by preincubation with GM1. Moreover, desialylated cells regained susceptibility to virus infection when coated with whole gangliosides or GM1 immediately after Clostridium perfringens neuraminidase treatment. The binding of SA-11 to whole gangliosides or GM1 was quantified by an ELISA procedure. The results suggest that gangliosides, mainly GM1, are part of the receptor structure for SA-11 of susceptible LLC-MK2 cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655958     DOI: 10.1099/0022-1317-72-10-2467

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin.

Authors:  Max Ciarlet; Juan E Ludert; Miren Iturriza-Gómara; Ferdinando Liprandi; James J Gray; Ulrich Desselberger; Mary K Estes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  SA-11 rotavirus binding to human serum lipoproteins.

Authors:  F Superti; L Seganti; M Marchetti; M L Marziano; N Orsi
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

Review 3.  Carbohydrate recognition by rotaviruses.

Authors:  Xing Yu; Helen Blanchard
Journal:  J Struct Funct Genomics       Date:  2013-11-19

4.  Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus.

Authors:  N Jourdan; M Maurice; D Delautier; A M Quero; A L Servin; G Trugnan
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope.

Authors:  C Delorme; H Brüssow; J Sidoti; N Roche; K A Karlsson; J R Neeser; S Teneberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Host membrane glycosphingolipids and lipid microdomains facilitate Histoplasma capsulatum internalisation by macrophages.

Authors:  Allan J Guimarães; Mariana Duarte de Cerqueira; Daniel Zamith-Miranda; Pablo H Lopez; Marcio L Rodrigues; Bruno Pontes; Nathan B Viana; Carlos M DeLeon-Rodriguez; Diego Conrado Pereira Rossi; Arturo Casadevall; Andre M O Gomes; Luis R Martinez; Ronald L Schnaar; Joshua D Nosanchuk; Leonardo Nimrichter
Journal:  Cell Microbiol       Date:  2018-12-07       Impact factor: 3.715

7.  Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8* core.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Ola Blixt; James C Paulson; Gerhard Wagner; Stephen C Harrison
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 8.  Investigating virus-glycan interactions using glycan microarrays.

Authors:  David F Smith; Richard D Cummings
Journal:  Curr Opin Virol       Date:  2014-07-01       Impact factor: 7.090

9.  Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus.

Authors:  P Borrow; M B Oldstone
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo.

Authors:  J E Ludert; N Feng; J H Yu; R L Broome; Y Hoshino; H B Greenberg
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.